Stock Screener App

無料 -

インストール

23.87

1.45% 0.4008

Arrivent Biopharma Inc (AVBP)

概要ニュース株価時系列ディスカッション予測

Arrivent Biopharma Inc (AVBP) 最新ニュース

Bank of America Corp DE Raises Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Millennium Management LLC Reduces Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Comparing Immutep (NASDAQ:IMMP) and ArriVent BioPharma (NASDAQ:AVBP) - Defense World

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Average Rating of “Buy” by Analysts - Defense World

Cencora Welcomes Lori J. Ryerkerk to Board of Directors - MyChesCo

BNP Paribas Financial Markets Decreases Stock Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 1,327 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Promising Outlook for ArriVent BioPharma: Buy Rating Justified by Upcoming EGFR PACC Mutant NSCLC Program Updates - TipRanks

Deutsche Bank AG Boosts Stock Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

ArriVent BioPharma (NASDAQ:AVBP) Shares Down 4.5% – Here’s What Happened - Defense World

Wall Street Zen Upgrades Atea Pharmaceuticals (NASDAQ:AVIR) to “Hold” - Defense World

Wall Street Zen Downgrades ArriVent BioPharma (NASDAQ:AVBP) to Strong Sell - Defense World

ArriVent BioPharma (NASDAQ:AVBP) Coverage Initiated at Jones Trading - Defense World

JonesResearch Begins Coverage on ArriVent Biopharma (AVBP) with - GuruFocus

ArriVent BioPharma (AVBP) Coverage Initiated with 'Buy' Rating | - GuruFocus

JonesResearch Begins Coverage on ArriVent Biopharma (AVBP) with Optimistic Outlook | AVBP Stock News - GuruFocus

Northern Trust Corp Purchases 10,498 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Northern Trust Corp Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

ArriVent BioPharma Reports Q1 2025 Financial Results and Highlights Key Achievements - MSN

Arbutus Biopharma Reports Q1 2025 Results, Clinical Developments, and Legal Progress - MyChesCo

When the Price of (AVBP) Talks, People Listen - news.stocktradersdaily.com

Q2 EPS Estimates for ArriVent BioPharma Cut by HC Wainwright - Defense World

ArriVent BioPharma (NASDAQ:AVBP) Price Target Raised to $40.00 - Defense World

Price T Rowe Associates Inc. MD Has $293,000 Stock Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

B. Riley Lifts Earnings Estimates for ArriVent BioPharma - Defense World

Synnovation Therapeutics Welcomes Rafael G. Amado, M.D., to Board of Directors - MyChesCo

ArriVent BioPharma (AVBP) Receives Price Target Increase by HC W - GuruFocus

Is ArriVent BioPharma (NASDAQ:AVBP) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

ArriVent Biopharma (AVBP) Price Target Increased by Analyst | AV - GuruFocus

ArriVent Biopharma (AVBP) Price Target Increased by Analyst | AVBP Stock News - GuruFocus

Voya Investment Management LLC Acquires Shares of 8,373 ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Tower Research Capital LLC TRC Has $43,000 Stock Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

ArriVent BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

ArriVent BioPharma, Inc. SEC 10-Q Report - TradingView

ArriVent Biopharma (AVBP) Projects Financial Stability Through 2 - GuruFocus

ArriVent Biopharma (AVBP) Projects Financial Stability Through 2026 | AVBP Stock News - GuruFocus

ArriVent (AVBP) Advances Oncology Pipeline with Key Milestones Ahead | AVBP Stock News - GuruFocus

ArriVent BioPharma Reports First Quarter 2025 Financial Results - The Manila Times

ArriVent BioPharma (AVBP) Expected to Announce Earnings on Wednesday - Defense World

How to Take Advantage of moves in (AVBP) - news.stocktradersdaily.com

Arrivent Biopharma Inc expected to post a loss of 66 cents a shareEarnings Preview - TradingView

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by Wells Fargo & Company MN - Defense World

ArriVent BioPharma (NASDAQ:AVBP) Shares Gap Down – Here’s Why - Defense World

Barclays PLC Grows Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Invesco Ltd. Takes Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by JPMorgan Chase & Co. - Defense World

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Short Interest Update - Defense World

Legal & General Group Plc Purchases 10,783 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

ArriVent BioPharma Appoints Dr. Merdad Parsey to Board of Directors - MyChesCo

Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors - The Manila Times

Avantor CEO Michael Stubblefield to Step Down, Search for Successor Underway - MyChesCo

ArriVent BioPharma appoints new board member By Investing.com - Investing.com South Africa

ArriVent BioPharma appoints new board member - Investing.com Australia

ArriVent BioPharma Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors - citybiz

ArriVent BioPharma (AVBP) Strengthens Leadership with New Board - GuruFocus

ArriVent BioPharma (AVBP) Strengthens Leadership with New Board Appointment | AVBP Stock News - GuruFocus

Ex-Gilead Chief Medical Officer Strengthens ArriVent Leadership as Breakthrough Cancer Drug Advances - Stock Titan

Mintz Achieves Ten Years of Consecutive Revenue Growth - Mintz

Arbutus Biopharma Showcases Promising Hepatitis B Research at EASL Congress - MyChesCo

Learn to Evaluate (AVBP) using the Charts - news.stocktradersdaily.com

Geode Capital Management LLC Cuts Stake in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

BDRX

$1.15

1.30%

ARGX

$584.68

0.75%

ALNY

$308.75

1.19%

ZLAB

$37.33

2.30%

ATHE

$4.68

3.35%

REGN

$492.00

1.78%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く